CClinicalTrials.gg
CompletedNCT00831883GET UPUpdated Dec 5, 2012

Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents

An interventional study of Partner-Specific IMB-based HIV risk reduction intervention and Healthy Lifestyle in Sexually Transmitted Diseases and Substance-Related Disorders, sponsored by Women and Infants Hospital of Rhode Island. Completed at 1 site in United States. Open to participants aged 15 Years to 18 Years. Per ClinicalTrials.gov, last updated 2012-12-05.

Sponsored by Women and Infants Hospital of Rhode Island · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
59
Allocation
Randomized
Ages
15 Years to 18 Years
Sex
All
01

Study summary

The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.

Read the detailed description

Incarcerated adolescents represent a group at high risk for health consequences associated with risky sexual behaviors. Condom use is more common with non-main than main sex partners and substance use in conjunction with sexual risk also appears to vary by partner type. The research team will conduct a small randomized trial to pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use. Participants will be randomized to a 5 session HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model, or a 5 session healthy lifestyles psychoeducation intervention, and then reassessed 3 months after their access to the general community is reinstated. The main hypothesis is that participants in the HIV risk reduction intervention condition will have lower levels of sex-related HIV risk behavior and of substance use in conjunction with sexual risk, relative to those in a healthy lifestyles psychoeducation intervention.

02

Conditions studied

  • Sexually Transmitted Diseases
  • Substance-Related Disorders

Keywords

  • Adolescent
  • Adolescent behavior
  • Health behavior
  • Sexual Behavior
  • Incarceration
  • Behavioral Intervention
  • Risk Reduction Behavior
03

In context

Sexually Transmitted Diseases

424 studies on the registry are indexed under Sexually Transmitted Diseases; 71 are open to participants now.

This study's enrollment of 59 is below the median of 470 across 346 interventional studies indexed under Sexually Transmitted Diseases.

Browse Sexually Transmitted Diseases studies →

Lead sponsor

Women and Infants Hospital of Rhode Island is the lead sponsor of 92 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • English-speaking ability
  • unprotected vaginal, anal, or oral intercourse at least once in the 6 months prior to incarceration or placement
  • marijuana use disorders, other non-injection drug use disorders, or substance use by a sexual partner during a sexual episode in the six months prior to incarceration or placement
  • sentence or placement length between 2 and 12 months
  • must plan to remain in the area for the 6 months following their release from the facility
  • must be willing to provide two pieces of contact information for follow-up

Exclusion criteria

Exclusion Criteria:

  • signs of psychosis (assessed through clinical assessment)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
59 participants (actual)

Study arms

  • Experimental
    Partner Specific IMB

    partner-specific HIV risk reduction intervention

    Behavioral: Partner-Specific IMB-based HIV risk reduction intervention

  • Placebo comparator
    HLS

    5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.

    Behavioral: Healthy Lifestyle

Interventions

  • BehavioralPartner-Specific IMB-based HIV risk reduction intervention

    5 session partner-specific HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model.

  • BehavioralHealthy Lifestyle

    5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.

06

What researchers measure

Primary outcomes

  1. lower levels of sex-related HIV risk behavior

    Time frame: 3 months

Secondary outcomes

  1. knowledge about STI transmission

    Time frame: 3 months

  2. partner-specific perceptions of STI risks

    Time frame: 3 months

  3. social norms, expectations and personal attitudes regarding partner-specific sexual behavior

    Time frame: 3 months

  4. partner-specific behavioral and communication skills

    Time frame: 3 months

07

Study locations

1 site
  • Women & Infants Hospital of Rhode Island
    Providence, Rhode Island 02905, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00831883
Lead sponsor
Women and Infants Hospital of Rhode Island
Collaborators
University of Rhode Island
Responsible party
Cynthia Rosengard (Cynthia Rosengard, Ph.D., Women and Infants Hospital of Rhode Island) — Principal investigator
First posted
Jan 29, 2009
Start date
Feb 2009
Primary completion
Jan 2011
Completion
Jan 2011
Last update
Dec 5, 2012

Study contacts

Cynthia Rosengard, PhD, MPH
principal investigator · Women & Infants of Rhode Island

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion